iKnowMed Content Updates Copied
Sept. 2, 2026
Intravenous Iron was added to the Therapeutic Interchange Management content group.
Aug. 31, 2026
Immunoglobulin (IVIG) was added to the Therapeutic Interchange Management content group.
Aug. 6, 2026
Nereus (Tradipitant Oral) was removed from the Fosaprepitant (NK-1 Antiemetics) Therapeutic Interchange Management content group.
July 20, 2026
The following updates were made to existing Therapeutic Interchange Management content groups:
- Denosumab (Prolia) has been updated to include denosumab-desu Subcutaneous (60 mg/mL – Osvyrti)
- Denosumab (Xgeva) has been updated to include denosumab-desu Subcutaneous (120 mg/1.7 mL – Jubereq)
June 5, 2026
Fosaprepitant (NK-1 Antiemetics) was added to the Therapeutic Interchange Management content groups.